Table 5.
Multivariate cox regression analysis of EORTC QLQ-C30 and OG25 symptom and functioning scales and items for patients with advanced disease
Multivariate cox regression analysis | Patients with advanced disease | |
---|---|---|
Single HRQoL items adjusted for clinical variables | HR (99% CI) | p |
Summary score | 0.75 (0.59–0.94) | 0.001 |
Global health status | 0.88 (0.75–1.04) | 0.05 |
Physical functioning | 0.91 (0.77–1.09) | 0.19 |
Role functioning | 0.89 (0.80–1.00) | 0.008 |
Fatigue | 1.16 (1.03–1.31) | 0.002 |
Nausea and vomiting | 1.13 (0.98–1.29) | 0.02 |
Pain | 1.16 (1.02–1.32) | 0.003 |
Insomnia | 1.13 (1.02–1.25) | 0.002 |
Appetite loss | 1.08 (1.00–1.18) | 0.01 |
Eating restrictions | 1.07 (0.98–1.18) | 0.05 |
Dry mouth | 1.07 (0.97–1.18) | 0.06 |
Body image | 1.05 (0.95–1.16) | 0.21 |
Worrying about weight loss | 1.06 (0.98–1.15) | 0.05 |
HRQoL health-related quality of life. HR hazard ratio. Values in bold were statistically significant at p < 0.01. Hazard ratios are given for every 10-point increase in HRQoL scores. Clinical covariates for the advanced subgroup were treatment type, performance status, peritoneal metastases, age, and marital status